Article Details
Retrieved on: 2024-10-15 14:33:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses clinical research on the monoclonal antibody combination casirivimab-imdevimab, showing its effectiveness in improving COVID-19 symptoms, patient-reported outcomes, and quality of life, relating to COVID-19 drug development and mind-body interventions.
Article found on: www.hematologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here